98%
921
2 minutes
20
Background: Kawasaki disease (KD) is an acute febrile illness and systemic vasculitis of unknown etiology that predominantly affects young children. The objective of this study was to investigate the correlation between myocardial and hepatic native T1 value and myocardial late gadolinium enhancement (LGE) in pediatric patients with KD.
Methods: In this cross-sectional retrospective study, 115 KD patients (50 in the acute phase, 65 in the chronic phase) and 40 age- and gender-matched controls underwent cardiac magnetic resonance (CMR) imaging with T1 mapping and LGE sequences. KD patients were subgrouped based on the myocardial LGE. Cardiac and hepatic T1 value as well as laboratory tests were also analyzed.
Results: Both cardiac and hepatic T1 value were significantly elevated in KD patients compared to controls, with the highest values noted in the acute phase (myocardial 1,393±70, 1,345±65, 1,303±62 ms; hepatic 813±25, 787±29, 758±38 ms; P=0.001, P=0.001, respectively). KD patients with myocardial LGE had significantly higher myocardial and hepatic T1 value in both the acute (1,442±66, 1,381±67 ms; 836±47, 803±30 ms, P=0.048, P=0.013, respectively) and chronic phases (myocardial 1,393±91, 1,331±50 ms; hepatic 811±39, 780±21 ms, P=0.012, P=0.001, respectively). Multivariate analysis demonstrated a significant correlation between the disease phase, albumin, and hepatic T1 value in KD patients. The combined of myocardial and hepatic T1 value significantly enhances the diagnostic performance of myocardial LGE, increasing the area under the curve (AUC) from 0.773 to 0.881 (P=0.013).
Conclusions: Elevated myocardial and hepatic T1 values correlate with myocardial LGE in KD, highlighting systemic involvement. The integration of these T1 values enhances the non-invasive diagnosis of myocardial involvement in KD, demonstrating their utility in assessing disease severity and progression.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11948400 | PMC |
http://dx.doi.org/10.21037/qims-24-791 | DOI Listing |
Ulus Travma Acil Cerrahi Derg
September 2025
Department of Histology and Embryology, Karadeniz Technical University Faculty of Medicine, Trabzoc-Türkiye.
Background: This study aims to show the changes in the liver, lung, kidney, and heart in the liver ischemia-reperfusion model in rats and the effect of quercetin on these changes histopathologically and immunohistochemically.
Methods: Eighteen Sprague Dawley rats were classified into three groups: Group 1 sham, Group 2 ischemia-reperfusion (IR), Group 3 ischemia-reperfusion + quercetin (IR+Q). For three days, distilled water was given to Group 1, and quercetin was given to Group 3 via gavage.
World J Hepatol
August 2025
Department of Hospital Medicine, Hartford Hospital, Hartford, CT 06102, United States.
Hepatitis C virus (HCV) infection has been increasingly associated with cardiovascular complications, particularly atherosclerosis and cardiomyopathy, in addition to its primary hepatic effects. Studies indicate a higher prevalence of carotid atherosclerosis in patients with chronic hepatitis C infection, with viral load and steatosis emerging as independent risk factors. HCV-related atherosclerosis appears to develop through complex processes involving endothelial dysfunction, inflammation, oxidative stress, and immune dysregulation.
View Article and Find Full Text PDFFASEB J
September 2025
Department of Biochemistry and Molecular Biology, Hubei Provincial Key Laboratory of Developmentally Originated Disease, Wuhan University School of Basic Medical Sciences, Wuhan, Hubei, China.
The redox imbalance in circulation can lead to inflammation and cellular damage in vascular walls, which plays a crucial role in atherogenesis. We previously designed an apolipoprotein E (ApoE) mimetic peptide, EpK, which can reduce atherosclerosis in ApoE-deficient mice by binding high-density lipoprotein (HDL). Meanwhile, hepatic overexpression of methionine sulfoxide reductase A (MsrA) can exert indirect anti-atherosclerotic effects.
View Article and Find Full Text PDFFront Cardiovasc Med
August 2025
Qingdao University, Laoshan District, Qingdao, Shandong, China.
Coronary microvascular dysfunction (CMD) is a high-risk factor for numerous cardiovascular events, and there is an increasing focus on the diagnosis and treatment of CMD itself or its association with cardiovascular diseases. However, some evidences suggest potential associations between CMD and multiple extracardiac pathologies, such as cerebrovascular, renal, pulmonary, retinal, hepatic, immune system diseases, and cancer. A shared pathological mechanism may underlie these connections, yet the relationship between CMD and other organs and systemic diseases remains unclear.
View Article and Find Full Text PDFNutrients
August 2025
Department of Nutrition Science, Purdue University, West Lafayette, IN 47907, USA.
Oral contraceptives (OCs) containing estrogen and/or progesterone are the second most common form of female contraception in the United States. While endogenously synthesized estrogen is known to provide protective effects against cardiometabolic diseases, exogenous forms such as OCs have been linked to increased susceptibility to cardiometabolic diseases and an elevated risk of myocardial infarction. The gut microbiota is thought to be a critical regulator of cardiometabolic disease risk; however, its interactions with OC use remain understudied.
View Article and Find Full Text PDF